Somavert is a new treatment option for acromegaly
Somavert is a new treatment option for acromegaly in Canada.
Acromegaly is caused by a benign pituitary tumour that results in oversecretion of growth hormone. If left untreated, it can cause serious complications such as disfigurement and blindness.
Somavert (pegvisomant) is for patients who don't respond to surgery, radiation, and/or other medical therapies for acromegaly.